Home  »  Industry   »  Incyte Corporation: Analyzing INCY Stock Trends...

Incyte Corporation: Analyzing INCY Stock Trends

The current stock price for Incyte Corporation (INCY) is $59.53. The stock experienced a significant increase during the last trading session, reaching $63.91 after opening at $63.43. It dipped to a low of $62.50 before ultimately closing at $62.55.

Incyte Corporation’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $86.29 on 01/26/23, and the lowest price during the same period was recorded at $60.56 on 09/18/23.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


52-week price history of INCY Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Incyte Corporation’s current trading price is -31.01% away from its 52-week high, while its distance from the 52-week low is -1.70%. The stock’s price range during this period has fluctuated between $60.56 and $86.29. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 2.32 million for the day, which was evidently higher than the average daily volume of 1.71 million over the last three months.

Financial Performance and Market Capitalization

Incyte Corporation (INCY) has experienced a quarterly decline of -5.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 13.54B and boasts a workforce of 2324 employees.

Analysts’ Ratings For Incyte Corporation

As of right now, 9 analysts are rating Incyte Corporation as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 11 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 63.98, with a change in price of -13.63. Similarly, Incyte Corporation recorded 1,793,217 in trading volume during the last 100 days, posting a change of -18.53%.

INCY Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for INCY stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.

INCY Stock Stochastic Average

Incyte Corporation’s raw stochastic average for the past 50 days is currently at 17.48%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 19.53%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 17.42% and 23.02%, respectively.

INCY Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The metric has seen a significant loss of -25.88% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -19.14%. Over the past 30 days, the price of INCY has leaped by -7.29%. And in the last five days, it has fallen by -7.58%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts